Spain · Delayed Price · Currency is EUR Faes Farma Statistics
Total Valuation
Faes Farma has a market cap or net worth of EUR 1.41 billion. The enterprise value is 1.69 billion.
| Market Cap | 1.41B |
| Enterprise Value | 1.69B |
Important Dates
The last earnings date was Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Jul 2, 2026 |
Share Statistics
Faes Farma has 311.45 million shares outstanding. The number of shares has increased by 0.51% in one year.
| Current Share Class | 311.45M |
| Shares Outstanding | 311.45M |
| Shares Change (YoY) | +0.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 8.25% |
| Float | 217.06M |
Valuation Ratios
The trailing PE ratio is 16.91 and the forward PE ratio is 14.01. Faes Farma's PEG ratio is 0.80.
| PE Ratio | 16.91 |
| Forward PE | 14.01 |
| PS Ratio | 1.99 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 5.40 |
| P/FCF Ratio | 22.59 |
| P/OCF Ratio | 17.58 |
| PEG Ratio | 0.80 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.02, with an EV/FCF ratio of 26.97.
| EV / Earnings | 20.04 |
| EV / Sales | 2.37 |
| EV / EBITDA | 26.02 |
| EV / EBIT | 61.30 |
| EV / FCF | 26.97 |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.58.
| Current Ratio | 2.63 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 6.93 |
| Debt / FCF | 7.18 |
| Interest Coverage | 2.82 |
Financial Efficiency
Return on equity (ROE) is 11.22% and return on invested capital (ROIC) is 8.73%.
| Return on Equity (ROE) | 11.22% |
| Return on Assets (ROA) | 5.03% |
| Return on Invested Capital (ROIC) | 8.73% |
| Return on Capital Employed (ROCE) | 2.21% |
| Weighted Average Cost of Capital (WACC) | 5.13% |
| Revenue Per Employee | 265,419 |
| Profits Per Employee | 31,422 |
| Employee Count | 2,611 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.42 |
Taxes
In the past 12 months, Faes Farma has paid 6.14 million in taxes.
| Income Tax | 6.14M |
| Effective Tax Rate | 6.77% |
Stock Price Statistics
The stock price has increased by +8.21% in the last 52 weeks. The beta is 0.34, so Faes Farma's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +8.21% |
| 50-Day Moving Average | 4.53 |
| 200-Day Moving Average | 4.77 |
| Relative Strength Index (RSI) | 51.85 |
| Average Volume (20 Days) | 116,404 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Faes Farma had revenue of EUR 711.06 million and earned 84.18 million in profits. Earnings per share was 0.27.
| Revenue | 711.06M |
| Gross Profit | 463.37M |
| Operating Income | 98.21M |
| Pretax Income | 90.62M |
| Net Income | 84.18M |
| EBITDA | 64.82M |
| EBIT | 27.51M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 136.78 million in cash and 449.29 million in debt, with a net cash position of -312.51 million or -1.00 per share.
| Cash & Cash Equivalents | 136.78M |
| Total Debt | 449.29M |
| Net Cash | -312.51M |
| Net Cash Per Share | -1.00 |
| Equity (Book Value) | 775.36M |
| Book Value Per Share | 2.49 |
| Working Capital | 324.82M |
Cash Flow
In the last 12 months, operating cash flow was 80.36 million and capital expenditures -17.83 million, giving a free cash flow of 62.53 million.
| Operating Cash Flow | 80.36M |
| Capital Expenditures | -17.83M |
| Depreciation & Amortization | 25.51M |
| Net Borrowing | 237.44M |
| Free Cash Flow | 62.53M |
| FCF Per Share | 0.20 |
Margins
Gross margin is 65.17%, with operating and profit margins of 13.81% and 11.84%.
| Gross Margin | 65.17% |
| Operating Margin | 13.81% |
| Pretax Margin | 12.74% |
| Profit Margin | 11.84% |
| EBITDA Margin | 8.90% |
| EBIT Margin | 3.78% |
| FCF Margin | 8.79% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 2.84%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 2.84% |
| Dividend Growth (YoY) | -28.49% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 66.19% |
| Buyback Yield | -0.51% |
| Shareholder Yield | 3.46% |
| Earnings Yield | 5.96% |
| FCF Yield | 4.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Faes Farma is 5.36, which is 16.78% higher than the current price. The consensus rating is "Buy".
| Price Target | 5.36 |
| Price Target Difference | 16.78% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 10.79% |
| EPS Growth Forecast (3Y) | 17.01% |
Stock Splits
The last stock split was on April 7, 2015. It was a forward split with a ratio of 1.02.
| Last Split Date | Apr 7, 2015 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Faes Farma has an Altman Z-Score of 2.48 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.48 |
| Piotroski F-Score | 5 |